细胞角蛋白14基因在非小细胞肺癌中的表达与意义

doi:10.6040/j.issn.1671-7554.0.2016.781

摘要/Abstract

摘要： 目的探讨细胞角蛋白14(CK14)基因的表达在非小细胞肺癌(NSCLC)发生、发展及转移中的意义。方法采用免疫组织化学染色法检测110例NSCLC患者癌组织、癌旁组织、正常肺组织中CK14的表达。采用Western blotting法检测12例患者新鲜组织中CK14的表达。应用非条件Logistic回归分析CK14表达水平与NSCLC患者各临床病理参数的关系。结果免疫组织化学染色结果显示,CK14在NSCLC癌组织中高表达,阳性表达率为68.18%,与癌旁组织和正常肺组织相比,差异有统计学意义(P<0.001)。CK14表达水平与NSCLC患者性别、组织类型、分化程度、分期以及淋巴结转移情况显著相关(P<0.05),与年龄无关(P>0.05)。Western blotting结果显示,CK14在NSCLC癌组织中的表达率较癌旁组织和正常肺组织高。非条件Logistic分析显示,低分化癌、病理分期Ⅱ期和Ⅲ期、CK14表达阳性是NSCLC患者发生淋巴结转移的重要危险因素(P<0.05)。结论 CK14表达在NSCLC的发生、发展和转移中发挥重要作用。CK14有望成为评估NSCLC生物学行为的重要指标。

关键词: 癌, 非小细胞肺, Logistic回归分析, 免疫组织化学, 细胞角蛋白14

Abstract: Objective To investigate the expression of CK14 and its significance in the occurrence, development and metastasis of non-small cell lung cancer(NSCLC). Methods A total of 110 NSCLC patients were involved in the study. The NSCLC cancerous tissues, the tissues adjacent to carcinoma and normal lung tissues of 110 patients and 12 patients were analyzed for CK14 expression by immunohistochemistry and Western blotting, respectively. The relationship between CK14 expression and clinical pathological parameters of NSCLC patients was analyzed by non-conditional Logistic regression analysis. Results The immunohistochemistry results showed that CK14 was overexpressed in NSCLC cancerous tissues which was significantly higher than tissues adjacent to carcinoma and normal lung tissues(P<0.001). In addition, the positive rate of CK14 was 68.18%. Its level was significantly correlated with sex, histopathologic type, differentiation of tumors, clinical stages and lymph node metastasis(P<0.05). However, no correlation was observed between CK14 level and age(P>0.05). Additionally, Western blotting result also showed that CK14 was overexpressed in NSCLC cancerous tissues compared with the tissues adjacent to carcinoma and normal lung tissues. The results of non-conditional Logistic regression analysis showed that poor differentation, staging Ⅱ and Ⅲ, and the positive expression of CK14 were important risk factors in lymph node metastasis of NSCLC(P<0.05). Conclusion CK14 plays a promotional role in the development and metastatic progression of NSCLC. CK14 expression would be a significant biomarker in evaluating the biological malignant behavior of NSCLC.

Key words: Carcinoma, non-small-cell lung, Cytokeratin 14, Logistic regression analysis, Immunohistochemistry

中图分类号:

R734.2

王永强,张维全,孙启峰,董晓鹏,彭传亮,张媛,赵小刚. 细胞角蛋白14基因在非小细胞肺癌中的表达与意义[J]. 山东大学学报（医学版）, 2017, 55(3): 83-87.

WANG Yongqiang, ZHANG Weiquan, SUN Qifeng, DONG Xiaopeng, PENG Chuanliang, ZHANG Yuan, ZHAO Xiaogang. Expression and significance of CK14 in non-small cell lung cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 83-87.

参考文献

[1] Chu PG, Lyda MH, Weiss LM, et al. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours[J]. Histopathology, 2001, 39(1):9-16.
[2] Reis Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray[J]. Virchows Archiv, 2003, 443(2):122-132.
[3] 赵鸿, 薛娣, 冷冬妮, 等. 受体三阴性乳腺癌中CK14和EGFR的检测及临床意义[J]. 临床医学工程, 2011, 18(6):862-863. ZHAO Hong, XUE Di, LENG Dongni, et al. Detection of CK14 and EGFR in triple-negative breast carcinoma and its clinical significance[J]. Medicine Healthcare Apparatus, 2011, 18(6):862-863.
[4] Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797):747-752.
[5] Chu PG, Lyda MH, Weiss LM, et al. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours[J]. Histopathology, 2001, 39(1):9-16.
[6] Winters R, Naud S, Evans MF, et al. Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases[J]. Head Neck Pathol, 2008, 2(4):265-271.
[7] Fulford LG, Reis-Filho JS, Ryder K, et al. Basal-like grade Ⅲ invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival[J]. Breast Cancer Res, 2007, 9(1): R4. DOI: 10. 1186/bcr1636.
[8] Singh A, Kapur S, Chattopadhyay I, et al. Cytokeratin immunoexpression in esophageal squamous cell carcinoma of high-risk population in Northeast India[J]. Appl Immunohistochem Mol Morphol, 2009, 17(5):419-424.
[9] Wetzels RH, Schaafsma HE, Leigh IM, et al. Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18[J]. Histopathology, 1992, 20(4): 295-303.
[10] 杨欣, 林冬梅. 2015版WHO肺癌组织学分类变化及其临床意义[J]. 中国肺癌杂志, 2016, 19(6):332-336. YANG Xin, LIN Dongmei. Changes of 2015 WHO histological classification of lung cancer and the clinical significance[J]. Chinese Journal of Lung Cancer, 2016, 19(6): 332-336.
[11] 杨龙海, 叶波, 魏星, 等. 最新国际肺癌TNM分期标准(第8版)修订稿解读[J]. 中国医刊, 2016, 51(9):22-25.
[12] Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma[J]. J Thorac Oncol, 2011, 6(2): 244-285.
[13] Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics[J]. CA Cancer J Clin, 2005, 55(2):74-108.
[14] Achen MG, Stacker SA. Molecular control of lymphatic metastasis[J]. Ann NY Acad Sci, 2008, 1131:225-234. doi: 10.1196/annals.1413.020.
[15] Kerbel RS. Tumor angiogensis[J]. N Engl J Med, 2008, 358(19):2039-2049.
[16] Tsubokawa F, Nishisaka T, Takeshima Y, et al. Heterogeneity of expression of cytokeratin subtypes in squamous cell carcinoma of the lung: with special reference to CK14 overexpression in cancer of high-proliferative and lymphogenous metastatic potential[J]. Pathol Int, 2002, 52(4):286-293.
[17] Cheung KJ, Gabrielson E, Werb Z, et al. Collective invasion in breast cancer requires a conserved basal epithelial program[J]. Cell, 2013, 155(7):1639-1651.
[18] Nobusawa A, Sano T, Negishi A, et al. Immunohistochemical staining patterns of cytokeratins 13, 14, and 17 in oral epithelial dysplasia including orthokeratotic dysplasia[J]. Pathol Int, 2014, 64(1):20-27.
[19] 孙莉, 董艳光, 徐志秀, 等. 七种细胞角蛋白在皮肤上皮性肿瘤中的表达[J]. 中华皮肤科杂志, 2006, 39(2): 68-70. SUN Li, DONG Yanguang, XU Zhixiu, et al. The expression of seven cytokeratins in skin epithelial tumors[J]. Chinese Journal of Dermatology, 2006, 39(2): 68-70.
[20] 于观贞, 陈颖, 顾小强, 等. CK7、CK14、CK19和CK20在胃肠癌转移诊断中价值的新发掘[J]. 肿瘤, 2006, 26(11):1015-1019. YU Guanzhen, CHEN Ying, GU Xiaoqiang, et al. New diagnostic value of CK7, CK14, CK19 and CK20 expression in detecting metastases of gastrointestinal carcinoma[J]. Tumor, 2006, 26(11):1015-1019.
[21] Moll R, Divo M, Langbein L, et al. The human keratins: biology and pathology[J]. Histochem Cell Biol, 2008, 129(6): 705-733.
[22] de Araújo VC1, de Sousa SO, Carvalho YR, et al. Application of immunohistochemistry to the diagnosis of salivary gland tumors[J]. Appl Immunohistochem Mol Morphol, 2000, 8(3):195-202.
[23] Chen Y, Cui T, Yang L, et al. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer[J]. Oncology, 2011, 80(5-6):333-340.
[24] Kanaji N, Bandoh S, Fujita J, et al. Compensation of type Ⅰ and type Ⅱ cytokeratin pools in lung cancer[J]. Lung Cancer, 2007, 55(3):295-302.
[25] Omary MB, Ku NO, Tao GZ, et al. “Heads and tails”of intermediate filament phosphorylation: multiple sites and functional insights[J]. Trends Biochem Sci, 2006, 31(7):383-389.
[26] Yamada A, Sasaki H, Aoyagi K, et al. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus[J]. Oncol Rep, 2008, 20(5):1021-1027.
[27] 张昆. CK14和HPV16E6 mRNA在早期宫颈癌患者外周血中的表达与宫颈癌微转移的关系[D]. 蚌埠:蚌埠医学院, 2011.
[28] 段楚骁, 李梦晨, 付圣灵, 等. CK14在低分化非小细胞肺癌中区分鳞癌和腺癌的意义[J]. 中华肺部疾病杂志(电子版), 2014, 7(6):651-652. DUAN Chuxiao, LI Mengchen, FU Shengling, et al. Expression of CK14 in poorly differentiated non-small cell lung cancer and its differential diagnostic significance[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2014, 7(6):651-652.

相关文章 15

[1]	王韶卿刘毅慧付婷婷成金勇刘强. 肝癌³¹磷磁共振波谱数据的分类[J]. 山东大学学报(医学版), 2209, 47(6): 42-46.
[2]	吕艳锋丁克王建新禹化龙贝绍生. 慢性肛瘘癌变诊疗分析[J]. 山东大学学报(医学版), 2209, 47(6): 55-57.
[3]	黄方康瑞吴春林. VEGFC、NF-κBp65及Survivin在鼻咽癌中的表达及临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 83-.
[4]	于德新蔡跃红马祥兴张晓明李传福. 肝细胞癌血管生成及其成熟度的临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 51-54.
[5]	李儆修,李忠慧,李闻天,王宇男,宋泽辉,庄大勇,贺青卿,周鹏. 光电检测仪在甲状腺癌术中的初步应用[J]. 山东大学学报 (医学版), 2026, 64(4): 31-37.
[6]	黄佩文, 王旭东. 治疗非小细胞肺癌新药:靶向c-Met蛋白的抗体药物偶联物Telisotuzumab Vedotin[J]. 山东大学学报 (医学版), 2026, 64(3): 124-130.
[7]	殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73.
[8]	古春青,郭睿思,周勤勤,刘恒辉,巴婉玉,孙士玲,王冰,郑玉玲,吴宿慧. 基于网络药理学和动物实验探讨酸枣仁-远志药对治疗乳腺癌相关性失眠的作用机制[J]. 山东大学学报 (医学版), 2026, 64(1): 99-108.
[9]	李晶,鞠苇杭,刘珂. 泛癌细胞类型特异性基因共表达模式[J]. 山东大学学报 (医学版), 2025, 63(9): 31-39.
[10]	李雪凯,孙淋涵,刘端瑞,倪阳. 乳酸化修饰在肿瘤炎癌进程中的功能与机制研究进展[J]. 山东大学学报 (医学版), 2025, 63(9): 65-76.
[11]	李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[12]	张润泽,薛付忠,杨帆. 基于多模态解耦对比学习的癌症亚型聚类方法[J]. 山东大学学报 (医学版), 2025, 63(8): 51-60.
[13]	李千,杨帆,薛付忠. 基于多模态数据融合的多癌种风险预测模型[J]. 山东大学学报 (医学版), 2025, 63(8): 79-85.
[14]	韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31.
[15]	刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed